VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Long until 2025

<< Previous

Bullboard Posts

Next >>

Comment by shawshank666on Oct 27, 2023 9:24am

54 Views

Post# 35703779

RE:RE:Long until 2025

I really like this statement. And Alvira said there has been 3-4 demos per month so there are 3-4 sales per month. We have nothing to worry about!!! 3-4 sales per month or 36-48 per year. Let's see when the third quarter and year-end results are out.
Statements of 4000 leads, 100% conversions of demos-yet the facts dont suppport it

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features